American Journal of Cancer Prevention
ISSN (Print): 2328-7314 ISSN (Online): 2328-7322 Website: Editor-in-chief: Nabil Abdel-Hamid
Open Access
Journal Browser
American Journal of Cancer Prevention. 2015, 3(2), 23-26
DOI: 10.12691/ajcp-3-2-1
Open AccessArticle

A Five Year Review of Cervical Cytology in Abakaliki, Nigeria

Leonard Ogbonna Ajah1, , Paul Olisaemeka Ezeonu1, Nelson Chukwudi Ozonu1, Chukwuemeka Anthony Iyoke2, Peter Onubiwe Nkwo2 and Monique Iheoma Ajah3

1Department of Obstetrics and Gynaecology,Federal Teaching Hospital, Abakaliki

2Department of Obstetrics and Gynaecology,University of Nigeria Teaching Hospital, Enugu

3Department of Microbiology, Ebonyi State University, Abakaliki

Pub. Date: March 20, 2015

Cite this paper:
Leonard Ogbonna Ajah, Paul Olisaemeka Ezeonu, Nelson Chukwudi Ozonu, Chukwuemeka Anthony Iyoke, Peter Onubiwe Nkwo and Monique Iheoma Ajah. A Five Year Review of Cervical Cytology in Abakaliki, Nigeria. American Journal of Cancer Prevention. 2015; 3(2):23-26. doi: 10.12691/ajcp-3-2-1


Background: Cervical cancer is the commonest gynecological cancer in Nigeria. The risk factors to cervical cancer are common in our environment. Objective: To determine the prevalence of cervical squamous cell abnormalities and the risk factors associated with the disease in Abakaliki, Nigeria. Methods: A 5 year retrospective study of cervical cytology at the Federal Teaching Hospital, Abakaliki from 1st January 2008 to 31st December 2012, was undertaken. Results: The prevalence of cervical squamous cell abnormalities in this study was 11.2%. These cervical squamous cell abnormalities comprised ASC-US (0.6%), LSIL (3.9%) and HSIL (6.7%). Cervical squamous cell abnormalities were significantly commoner among clients who were smokers, live in rural areas, had high parity and history of vaginal discharge/itching. However, age at coitarche, educational qualification and use of hormonal contraceptives did not have any effect on cervical squamous cell abnormality in this study. Conclusion: There is high prevalence of cervical squamous cell abnormality in Abakaliki. So there is need for public sensitization about this problem and the various ways of stemming the tide.

cervical Cancer cervical cytology risk factors Abakaliki

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  Anorlu RI, Igwilo CI, Akanmu AS, Banjo AA, Odunukwe NN, Okany CC, et al. Prevalence of abnormal cervical smears among patients with HIV in Lagos, Nigeria. West Afr J Med 2007 Apr-Jun; 26 (2): 143-7.
[2]  Parkin DM, Ferlay J, Hamdi-Cherif M, Sitas F, Thomas JO. Cancer in Africa: Epidemiology and Prevention. IARC Scientific Publications. No. 153. Lyon: IARC Press, 2003.
[3]  Parkin DM, Whelan SL, Ferlay J, Teppo L and Thomas DB (editors). Cancer Incidence in Five Continents, Vol VIII. IARC Scientific Publication No. 155. Lyon: IARC, 2002.
[4]  Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002 Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base; Lyon, 2004.
[5]  World Health Organization. Nigeria:Human Papillomavirus and Related Cancers, Fact Sheet 2014. WHO/ICO HPV Information Centre. Institut Català d’Oncologia Avda. Gran Via de l’Hospitalet, 199-20308908 L’Hospitalet de Llobregat (Barcelona, Spain). e-mail: adress:
[6]  Galadanci HS, Mohammed AZ, Uzoho CC, Jido TA, Ochicha O. Gynaecological Malignancies Seen in a Tertiary Health Facility in Kano, Northern Nigeria. Trop J Obstet Gynaecol. 2003; 20 (2): 105-108.
[7]  Greenlee RT, Hill-Norman MB, Murray T, Thun M. Cancer Statistics 2001. Cancer J Clin 2001; 51: 15-36
[8]  Dim CC, Ezegwui HU, Ikeme AC, Nwagha UI, Onyedum CC. Prevalence of cervical squamous intraepithelial lesions among HIV-positive women in Enugu, South-eastern Nigeria. J Obstet Gynaecol. 2011 Nov; 31 (8): 759-62.
[9]  Azodi M, Roy W. Premalignant lesions of the lower genital tract. In: Okonofua F,Odunsi K, editors. Contemporary Obstetrics and Gynaecology in DevelopingCountries. Benin City: Women’s Health and Action Research Center; 2003: 255-88.
[10]  Chan MK, Wong FW. The Papanicolaou Test-Its Current Status. Hong Kong Practitioner 1990; 12. Available from:
[11]  Guilbert E, Boroditsky R, Black A, Kives S, Leboeuf M, Mirosh M, et al. Canadian Consensus Guideline on Continuous and Extended Hormonal Contraception, 2007. J Obstet Gynaecol Can 2007; 29: S1-32.
[12]  Kabir M, Iliyasu Z, abubakar IS, Mahbooh S. Awareness and Practice of Cervical Cancer Screening Among Female Health Professionals in Murtala Mohammed Specialist Hospital, Kano. Nig Post Grad Med J. 2005: 12 (3):179-182.
[13]  Eze JN, Umeora OU, Obuna VE, Ejikeme BN. Cervical cancer awareness and cervical screening uptake at the mater Misericordiae Hospital, Afikpo, South-East Nigeria. Ann Afr Med J 2012, 11: 238-43.
[14]  Chinaka CC, Nwazue UC. Awareness of cervical cancer and its screening in Abakaliki,Nigeria. African Journal of Cellular Pathology. 2013; 1 (1): 47-51.
[15]  Chukwuali LI, Onuigbo WIB, Mgbor NC. Cervical cancer screening in Enugu.Trop J Obs Gyn. 2003; 20 (2): 147-154.
[16]  Obaseki D E, Nwafor C C. Cervical Cancer Screening In Benin City, South-South Nigeria. IOSR-JDMS. 2013; 5 (1): 16-19.
[17]  Ezechi OC, Pettersson KO, Okolo CA, Ujah IAO, Ostergren PO. The Association between HIV Infection, Antiretroviral Therapy and Cervical Squamous Intraepithelial Lesions in South Western Nigerian Women. PLoS ONE. 2014; 9 (5): e97150.
[18]  Thomas JO; Ojemakinde KO; Ajayi IO; Omigbodun AO; Fawole OI; Oladepo O. Population-based prevalence of abnormal cervical cytology findings and local risk factors in Ibadan, Nigeria: implications for cervical cancer control programs and human papilloma virus immunization. Acta Cytol; 56 (3): 251-8, 2012.
[19]  Pimentel VM, Jiang X, Mandavilli S, Umenyi NC, Schnatz PF. Prevalance of high risk cervical human papillomavirus and squamous intraepithelial lesions in Nigeria. J Low GenitTract Dis. 2013; 17 (2): 203-209.
[20]  Yakasai IA, Abdullahi HM, Mohammed AZ, Galadanci H. Prevalance of cervical dysplasia among women in Kano Municipal,Kano State, Nigeria. Journal of Medicine in the Tropics. 2012; 14 (1): 64-68.
[21]  Ahmed SA, Ayuba HU, Maiangwa A, Vakkai VI, Dashe DR, Joel R, et al. Prevalence of squamous intraepithelial lesions in Jalingo, Nigeria. African Journal of Cellular Pathology. 2013; 1:1:19-22.
[22]  Mahmoud M, Khalida M. Prevalence of abnormal cervical smears among females in Kirkuk governorate. Journal of Kirkuk University Scientific Studies. 2012; 7 (2).
[23]  Atilgan R, Celik A, Boztosun A, Ilter E, Yalta T, Ozercan R. Evaluation of cervical cytological abnormalities in Turkish population. Indian J Pathol Microbiol 2012; 55: 52-5.
[24]  Bayo S, Bosch FX, de Sanjose S, Munoz N, Combita AL, Coursaget P, et al. Risk factors of invasive cervical cancer in Mali. International Journal of Epidemiology 2002; 31: 202-09.
[25]  Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. The 2001 Bethesda System: Terminology for Reporting Results of Cervical Cytology. JAMA. 2002; 287 (16): 2114-2119.
[26]  National Cancer Institute, surveillance epidemiology and end results. Available from:
[27]  National Population Commission [Nigeria] and ICF International. 2014. Nigeria Demographic and Health Survey 2013. Rockville, Maryland, USA: National Population Commission and ICF International.
[28]  Sule ST, Shehu MS. Cervical Cancer management in Zaria, Nigeria. Afr J Health Sci. 2007; 14 (3-4): 149-153
[29]  Fonn S,Bloch B,Madina M,Carpenter S, Cronge H,Maise C.Prevalence of pre-cancerous lesions and cervical cancer.South Afr Med J. 2002; 92 (1): 148-156.
[30]  Franceschi S. The IARC commitment to cancer prevention: the example of papillomavirus and cervical cancer. Recent Results in Cancer Research 2005; 166: 277-297.